Clinical trial may be completed in September
Tilray-sponsored research at the University of California is looking at the effectiveness of CBD and THC in essential tremor, according to recently updated clinical trial records.
“Investigators plan to conduct the first double-blind, placebo-controlled clinical trial of cannabis in an oral capsule.”
According to the record, investigators plan to conduct “the first double-blind, placebo-control clinical trial of cannabis in an oral capsule.”
They say although no controlled trials have been conducted (until now), patients with ET have long reported tremor benefits with the use of cannabis.”
Tilray previously announced approval from the DEA to import a medical cannabis product into the United States from Canada for “a clinical trial.”
Essential tremor affects up to 1% of the population and up to 5% of people over the age of 65. The tremor most often affect the hands, head, voice and legs.
The International Essential Tremor Foundation is also supporting the study.
